Occupational Activity
Premier Inc. Reports Strong Q4 FY2025 Results Exceeding Guidance Despite Segment Challenges
Premier Inc.; Q4 FY2025; financial results; net revenue; adjusted EBITDA; Supply Chain Services; Performance Services
AsedaSciences and GenEvolutioN Announce Sales & Marketing Agreement to Integrate Genotoxicity Screen into 3RnD Platform
AsedaSciences; GenEvolutioN; 3RnD; genotoxicity screen; sales agreement; New Approach Methods; NAMs
J&J Targets $100 Billion in 2026 Sales Despite Stelara Patent Cliff
Johnson & Johnson; J&J; 2026 sales; $100 billion; Stelara; patent cliff; DARZALEX; oncology; MedTech; Shockwave Medical
Angelini Pharma Appoints Sergio Marullo di Condojanni as New CEO
Angelini Pharma; Sergio Marullo di Condojanni; CEO Appointment; Angelini Industries
Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
Rentschler Biopharma; Executive Board Changes; Interim CEO; Corporate Strategy; Uwe Buecheler; Benedikt von Braunmuehl; Christiane Bardroff
Pfizer Exits ViiV Healthcare as Shionogi Doubles Stake in $2.13 Billion Deal
Pfizer; Shionogi; ViiV Healthcare; GSK; HIV; stake sale
Dr Melanie Ivarsson Appointed CEO of Health Data Research Service
Dr Melanie Ivarsson; Health Data Research Service; HDRS; CEO appointment; UK health data; medical research
Argenx Appoints Karen Massey as New CEO in Leadership Transition
argenx; Karen Massey; CEO; Tim Van Hauwermeiren; leadership transition; rare diseases; Vyvgart
FDA Clears BrainSpace Intellidrop: Automated Neuro Device Tackling ICU Nursing Shortages and Advancing Physical AI
FDA clearance; BrainSpace; Intellidrop; ICU nursing shortages; brain fluid management; Physical AI; neuro injury
FDA Policy Tracker: 2025 Was a Year of Change
FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements